Breaking News

Axplora Expands Farmabios Site in Gropello Cairoli

The latest phase of the $60M investment program includes construction of a new 4,500 m² three-story R&D and laboratory hub.

Author Image

By: Charlie Sternberg

Associate Editor

Axplora's Farmabios site.

Axplora, a global CDMO Partner, has reached a major milestone in its $60 million investment program in highly potent API (HPAPI) manufacturing at its Farmabios site in Gropello Cairoli. The latest phase includes construction of a new 4,500 m² three-story R&D and laboratory hub designed to accelerate development, expand execution capacity and deliver cost-efficient high-potency manufacturing at scale. The investment builds on recent expansions across the Axplora network, including the mult...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters